Previous investigation in severe acute respiratory syndrome coronavirus (SARS-CoV) [3] and Middle East respiratory syndrome coronavirus (MERS-CoV) [4] infections indicated that IFNβ might be a valid candidate to treat COVID-19. Here, IFNB1 is linked to COVID-19.